CCDC 1982339: Experimental Crystal Structure Determination
Pei‐Pei Kung(Pfizer (United States)), Martin A. Edwards(University of Utah), Alexei Brooun(Pfizer (United States)), Wei Liu(Dalian Institute of Chemical Physics), Lisa Nguyen(Pfizer (United States)), Penney Khamphavong(Pfizer (United States)), K.S. Gajiwala(Pfizer (United States)), Luke R. Zehnder(University of Minnesota), Huichun Zhu(Pfizer (United States)), Robert S. Kania(RG Biopharma (United States)), Michael R. Collins(Pfizer (United States)), Manfred Kraus(Harvard University), Shikhar Sharma(Pfizer (United States)), Shuibo Xin(WuXi AppTec (China)), Patrick Bingham(Pfizer (United States)), Shinji Yamazaki, Shuiwang Wang(WuXi AppTec (China)), Susan E. Kephart(Pfizer (United States)), Scott C. Sutton, Robert A. Kumpf(Pfizer (United States)), Neal W. Sach(Pfizer (United States)), Jillian E. Spangler(Scripps Research Institute), Martin Wythes(Pfizer (United States)), Hovhannes J. Gukasyan(Pfizer (United States)), Karen A. Maegley(Pfizer (United States)), Wenyue Hu(Beijing University of Chinese Medicine), Dominique Verhelle(Pfizer (United States)), Sean Uryu(Pfizer (United States)), Dan Richter(Pfizer (United States)), Cody Krivacic(Pfizer (United States)), Hui Wang(Central South University), JinJiang Zhu(Pfizer (United States)), Dac M. Dinh(Pfizer (United States)), Albert Stewart(Pfizer (United States)), Shijian Ren(WuXi AppTec (China)), John Sherrill(Pfizer (United States)), Robert A. Rollins(Pfizer (United States)), Rita Grantner(Pfizer (United States)), Buwen Huang(Pfizer (United States)), Connie Fan(Pfizer (United States))
Cited by 0
Related Papers
Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
|Journal of Medicinal Chemistry|2011|924
Metal-free efficient photocatalyst for stable visible-light photocatalytic degradation of refractory pollutant
|Applied Catalysis B: Environmental|2017|545